Kelly Hunt to Risk
This is a "connection" page, showing publications Kelly Hunt has written about Risk.
Connection Strength
0.035
-
A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA. 2011 May 11; 305(18):1873-81.
Score: 0.021
-
Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care. 2004 Nov; 27(11):2676-81.
Score: 0.013